(Q28175138)
Statements
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II) (English)
0 references
February 2001
0 references
32
0 references
2
0 references
438-41
0 references